You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) POLYETHYLENE GLYCOL 200


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POLYETHYLENE GLYCOL 200 excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing POLYETHYLENE GLYCOL 200 excipient

POLYETHYLENE GLYCOL 200 Market Analysis and Financial Projection

Last updated: February 8, 2026

What Are the Market Dynamics for Polyethylene Glycol 200 (PEG 200)?

Polyethylene glycol 200 (PEG 200) is a clear, colorless, water-soluble polymer with a wide range of pharmaceutical, cosmetic, and industrial applications. It acts primarily as a solvent, plasticizer, and viscosity regulator, influencing its demand trajectory. The market for PEG 200 is driven by expansion across multiple sectors but faces challenges related to regulatory scrutiny and supply chain constraints.

Demand Drivers

  • Pharmaceutical Industry: PEG 200 is used extensively in oral, topical, and injectable formulations. It facilitates drug solubility and stability, particularly for poorly water-soluble compounds.
  • Personal Care Sector: It is a common additive in creams, lotions, and cosmetics due to its solubilizing and emollient properties.
  • Industrial Applications: PEG 200's solvent properties have applications in lubricants, antifreeze agents, and the manufacturing of resins.

Market Size and Growth

  • The global PEG market, including all molecular weights, was valued at approximately $1.3 billion in 2022.
  • PEG 200-specific volume is a subset, expected to account for about 25-30% of this value, reflecting its dominant application in pharmaceuticals and cosmetics.
  • The compound's market is projected to grow at a CAGR of approximately 4-5% from 2023 to 2028, driven by increasing pharmaceutical R&D and emerging markets’ demand.

Regional Trends

  • North America: Holds the largest market share, driven by high pharmaceutical R&D activity and stringent regulatory standards that favor well-established excipients like PEG 200.
  • Europe: Second-largest market, with growth influenced by the cosmetic industry and regulatory harmonization under EMA.
  • Asia-Pacific: Exhibits the fastest growth, owing to expanding pharmaceutical manufacturing, increased cosmetic consumption, and less restrictive regulatory frameworks.

Competitive Landscape

Major players include BASF, Ineos, Dow, and Sinochem. These companies focus on capacity expansion, R&D innovation, and strategic alliances. The market also faces ongoing pressure to develop alternative excipients with similar functional properties but improved safety profiles.

What Are the Key Financial Trends for PEG 200?

Financial benchmarking of PEG 200-specific markets is often aggregated within the broader PEG market; however, some indicators can be extracted:

Pricing Trends

  • Prices for PEG 200 have experienced stable fluctuations, ranging from $2.50 to $4.00 per kg in 2022.
  • Price volatility stems from raw material costs (ethylene oxide), supply chain disruptions, and regulatory costs.

Cost Factors

  • Raw material costs account for approximately 60-70% of manufacturing expenses.
  • Regulatory compliance investments, such as purity standards and manufacturing practices, influence overall costs.

Investment Patterns

  • Significant capital expenditure occurs in capacity expansion, with some companies investing $50-$100 million in new facilities or upgrades for PEG production lines.
  • R&D investments focus on developing derivatives and improving biocompatibility for pharmaceutical applications.

Demand Impacts on Revenue

  • Pharmaceutical applications contribute roughly 60% of PEG 200 sales revenue.
  • Cosmetic sector accounts for an estimated 25%, with the remaining 15% distributed among other industrial uses.

Regulatory and Market Barriers

  • Tightening regulations around impurities (e.g., ethylene oxide residues) increase compliance costs.
  • Competition from alternative excipients like PEG derivatives (e.g., PEG 400) and non-PEG-based solvents influences pricing and market share.

How Do Regulatory and Supply Chain Factors Affect Market and Financial Outcomes?

Regulatory agencies such as the FDA and EMA impose strict quality standards. Compliance involves rigorous testing for residual monomers, impurities, and batch consistency, which can delay production and elevate costs.

Supply chain disruptions, especially during the COVID-19 pandemic, led to raw material scarcity, impacting pricing and availability. Companies that secured integrated supply chains or diversified sources mitigated risks.

What Are the Future Outlooks?

  • Growth is expected to accelerate in emerging markets due to expanding pharmaceutical manufacturing capacities.
  • Innovation in PEG derivatives and specialty grades tailored for biopharmaceuticals could open new revenue streams.
  • Environmental and safety regulations may lead to increased costs but also encourage development of greener production processes.

Key Takeaways

  • The PEG 200 market is shaped by pharmaceutical, cosmetic, and industrial demand with an expected CAGR of 4-5% until 2028.
  • Regional growth varies; Asia-Pacific outpaces North America and Europe in expansion rate.
  • Pricing remains relatively stable but risk-sensitive to raw materials and regulatory costs.
  • Regulatory standards significantly influence manufacturing costs and market access.
  • Companies investing in capacity expansion and R&D are better positioned for future growth.

FAQs

1. What are the main applications of PEG 200 in pharmaceuticals?

PEG 200 is primarily used as a solvent and excipient to increase drug solubility, for softgel capsule production, and as a plasticizer in topical formulations.

2. How does regulation impact PEG 200 markets?

Regulations emphasize purity, residual solvent levels, and manufacturing quality. Increased oversight raises production costs but ensures safety and market acceptance.

3. Who are the leading manufacturers of PEG 200?

Major players include BASF, Ineos, Dow, and Sinochem. These companies hold significant global capacity and invest in technological innovation.

4. What factors could inhibit market growth?

Supply chain disruptions, regulatory tightening, and the development of alternative excipients could slow growth or reduce market share.

5. What future innovations are expected in PEG 200 applications?

Development of biocompatible and environmentally sustainable PEG derivatives, along with higher purity grades for specialized pharmaceutical uses.


References

[1] Markets and Markets, "Polyethylene Glycol Market by Molecular Weight," 2022.
[2] Grand View Research, "PEG Market Analysis," 2022.
[3] U.S. FDA Guidance Documents, 2021.
[4] European Medicines Agency, "Guidelines on excipients," 2021.
[5] Industry Reports, "Polyethylene Glycol Industry Trends," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.